Esperion
Cardiometabolic Drug Development, Therapies
- B2B
About Esperion
Developing and delivering innovative cardiometabolic and rare/orphan disease therapies. Marketing oral, once-daily, non-statin therapies for high cholesterol and cardiovascular disease risk.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- ann arbor, michigan, United States
- Founded
- 2008
- Revenue
- $403MFY2025, publicly reported
- Website
- esperion.com
Esperion at a glance
Esperion is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in ann arbor, michigan, United States.
Esperion was founded in 2008.
Esperion has 251–1,000 employees.
Esperion's revenue is $403M (FY2025, publicly reported).
Selling to companies like Esperion?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies